Accessibility Menu

eXoZymes

(NASDAQ) EXOZ

Current Price$7.41
Market Cap$62.32M
Since IPO (2024)-15%
5 YearN/A
1 Year-43%
1 Month-25%

eXoZymes Financials at a Glance

Market Cap

$62.32M

Revenue (TTM)

$0.00

Net Income (TTM)

-$9.67M

EPS (TTM)

-$1.15

P/E Ratio

-6.39

Dividend

$0.00

Beta (Volatility)

0.49 (Low)

Price

$7.41

Volume

226

Open

$7.41

Previous Close

$7.41

Daily Range

$7.41 - $7.61

52-Week Range

$7.08 - $18.40

Estimated Earnings Date

Mar 31, 2026

EXOZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About eXoZymes

Industry

Biotechnology

Employees

32

CEO

Michael Heltzen

Headquarters

Monrovia, NV 91016, US

EXOZ Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-186%

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

-15.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$62.32M

Shares Outstanding

8.48M

Volume

226

Avg. Volume

5.34K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$9.72M

EBITDA

-$8.98M

Operating Cash Flow

-$6.50M

Capital Expenditure

-$169.92K

Free Cash Flow

-$6.67M

Cash & ST Invst.

$3.04M

Total Debt

$1.24M

eXoZymes Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$74.15K

-5.2%

Gross Margin

0.00%

N/A

Market Cap

$62.32M

N/A

Market Cap/Employee

$2.01M

N/A

Employees

31

N/A

Net Income

-$2.37M

-27.7%

EBITDA

-$2.30M

-28.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.44M

-83.0%

Total Debt

$1.16M

-12.2%

Accounts Receivable

$302.86K

-49.1%

Inventory

$0.00

N/A

Long Term Debt

$829.98K

-23.8%

Short Term Debt

$334.90K

+41.4%

Return on Assets

-2.41%

N/A

Return on Invested Capital

-4.17%

N/A

Free Cash Flow

-$1.58M

-35.8%

Operating Cash Flow

-$1.52M

-34.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TLSATiziana Life Sciences Ltd
$1.10-0.90%
TILInstil Bio, Inc.
$7.61-3.91%
ESLAEstrella Immunopharma, Inc.
$1.00-2.91%
TVGNTevogen Bio Holdings Inc.
$9.15-8.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.98-0.06%
SNAPSnap
$5.16-0.10%
RXTRackspace Technology
$6.21+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$79.93-0.06%

Questions About EXOZ

What is the current price of eXoZymes?

eXoZymes is trading at $7.41 per share.

What is the 52-week range for eXoZymes?

Over the past 52 weeks, eXoZymes has traded between $7.08 and $18.40.

How much debt does eXoZymes have?

As of the most recent reporting period, eXoZymes reported total debt of $1.16M.

How much cash does eXoZymes have on hand?

eXoZymes reported $1.44M in cash and cash equivalents in its most recent financial results.

What is eXoZymes’s dividend yield?

eXoZymes does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.